Skip to main content
. 2022 Sep 1;7(36):32078–32100. doi: 10.1021/acsomega.2c03325

Table 4. Antiproliferative Activity of Synthesized 1,2,3-Triazole (18an) against an NCI Panel of 60 Human Cancer Cell Lines.

PANELNME comp no. 16c 18a 18b 18c 18d 18e 18f 18g 18h 18i 18j 18k 18l 18m 18n
leukemia CCRF-CEM 70.56 59.43 92.94 76.55 40.10 116.05 84.49 81.06 85.57 36.52 97.09 83.96 97.30 58.35 61.14
HL-60(TB) 76.37 93.01 87.80 83.86 41.06 95.54 83.95 110.2 100.27 47.68 96.30 89.26 91.54 70.85 88.43
K-562 89.43 79.40 53.52 60.82 44.62 81.37 51.89 44.88 83.08 51.53 59.00 72.74 81.62 47.60 66.32
MOLT-4 83.43 54.59 71.73 47.68 16.29 84.05 68.65 64.23 80.63 20.66 84.80 67.45 74.84 14.78 69.97
RPMI-8226 84.37 37.90 75.30 56.33 47.56 90.71 77.63 73.14 73.29 39.91 89.81 75.33 81.80 58.26 69.27
SR 90.57 62.33 65.77 61.39 48.53 79.78 27.12 39.18 81.95 45.13 41.51 68.94 73.39 24.73 63.80
non-small cell lung cancer A549/ATCC 96.36 94.07 57.07 81.77 64.07 59.42 46.49 85.48 56.83 65.65 42.61 76.78 80.64 48.20 78.59
EKVX 86.35 74.29 75.34 51.21 54.00 81.06 77.24 75.25 69.05 58.81 92.14 65.19 78.32 81.03 79.03
HOP-62 85.81 120.28 61.55 89.31 79.25 11.33 95.67 103.84 82.74 78.10 88.76 67.99 46.72 88.63 65.10
HOP-92 83.48 103.88 53.02 71.92 79.43 –3.27 51.60 86.49 76.24 57.55 86.10 55.58 4.63 65.16 45.94
NCI-H226 100.60 79.51 63.78 54.16 59.73 66.35 50.55 80.08 73.48 56.87 72.34 51.40 73.35 54.94 70.24
NCI-H23 94.13 91.88 64.87 72.88 64.51 56.64 68.51 45.49 66.55 62.45 79.35 74.89 68.25 64.54 60.06
NCI-H322M 91.13 106.92 83.48 104.66 91.28 95.25 82.51 92.29 103.37 94.44 90.10 105.20 92.68 94.96 99.60
NCI-H460 103.61 97.03 65.04 88.73 78.43 75.06 45.51 78.17 62.92 84.19 14.61 79.49 89.03 45.78 74.17
NCI-H522 86.86 85.53 62.93 67.33 51.40 55.44 61.51 58.92 80.13 61.88 83.09 66.40 57.14 63.51 41.63
colon cancer COLO 205 105.96 99.03 91.10 102.61 71.71 104.99 53.63 121.73 94.43 78.01 74.25 97.16 111.74 95.57 112.90
HCC-2998 108.39 93.30 75.87 94.66 91.88 92.47 93.52 107.31 91.41 106.48 111.05 94.86 100.56 89.49 95.80
HCT-116 94.11 96.71 38.23 72.22 49.66 53.13 29.82 32.09 18.65 49.09 12.49 47.86 60.15 29.43 41.92
HCT-15 100.88 88.04 65.29 81.43 53.84 79.57 29.35 71.79 80.93 62.42 56.79 91.65 82.81 66.16 82.35
HT29 103.79 99.48 79.57 97.34 76.66 82.28 78.27 108.14 100.11 22.55 96.61 102.98 97.40 77.55 94.43
KM12 100.37 96.04 87.72 94.27 62.97 93.06 82.66 86.78 91.32 63.85 84.99 96.37 99.29 71.66 94.59
SW-620   98.70 76.75 97.41 80.24 89.26 29.90 86.83 80.92 92.93 38.71 101.33 92.72 71.03 91.70
CNS cancer SF-268 77.04 92.33 95.38 85.96 82.41 52.34 58.39 88.77 73.15 78.08 83.86 69.92 58.88 71.57 71.71
SF-295 103.18 88.16 55.55 66.84 56.38 41.76 80.45 70.15 96.45 60.45 72.87 64.41 45.20 54.05 63.24
SF-539 93.56 96.00 67.72 73.07 75.23 66.88 5.30 43.12 69.79 66.99 16.35 68.43 44.60 59.74 51.16
SNB-19 95.32 74.44 78.63 67.87 61.27 49.98 81.31 84.82 73.39 66.43 97.17 53.11 55.68 83.59 57.66
SNB-75 56.78   41.60   60.00 7.99 47.20 78.02   56.57 65.15   10.58 54.57 47.32
U251 98.73 93.80 57.71 102.61 80.61 54.40 48.23 82.82 40.06 62.83 50.97 65.37 61.60 83.86 63.36
melanoma LOX IMVI 92.96 92.33 59.71 75.06 56.37 80.73 50.61 62.72 71.40 62.00 80.73 81.38 76.70 72.59 74.03
MALME-3M 90.29 88.78 68.35 87.23 68.22 79.26 77.44 76.19 71.40 70.30 80.81 96.02 78.28 75.36 85.41
M14 95.93 85.67 90.80 93.39 55.87 102.02 89.03 88.83 82.48 65.91 92.12 102.20 94.79 88.23 97.23
MDA-MB-435 102.18 97.17 84.94 93.75 66.50 98.16 91.28 88.25 99.53 74.94 74.88 103.84 100.50 81.26 98.30
SK-MEL-2 101.97 91.22 83.62 95.46 53.30 71.68 93.67 64.50 95.86 66.32 110.78 84.61 78.55 79.97 78.04
SK-MEL-28 106.36 99.70 86.95 76.60 69.78 96.28 89.28 87.77 98.47 85.31 91.55 89.56 94.93 85.39 96.54
SK-MEL-5 97.72 77.37 62.77 89.51 5.29 60.43 71.91 35.89 86.20 16.33 78.75 65.24 70.80 31.05 55.65
UACC-257 112.93 101.28 85.53 72.07 60.33 91.96 91.04 69.39 92.03 71.22 103.84 69.92 94.00 68.74 86.34
UACC-62 81.15 64.23 65.67 108.08 39.56 65.59 69.35 53.53 65.91 48.01 72.06 64.41 69.54 56.65 65.15
ovarian cancer IGROV1 89.12 88.78 80.15 95.28 87.05 72.31 83.14 78.76 106.74 78.93 102.20 97.38 81.86 81.49 89.93
OVCAR-3 94.85 116.94 82.26 70.95 83.57 101.33 60.12 107.92 98.44 80.34 102.85 107.56 105.46 94.05 104.69
OVCAR-4 78.72 95.26 52.67 106.44 33.26 49.69 53.41 63.75 63.65 45.26 45.13 73.07 71.43 55.29 49.55
OVCAR-5 93.28 69.23 80.72 72.31 93.08 91.71 86.36 101.94 98.00 95.61 97.48 101.77 94.92 97.97 105.21
OVCAR-8 99.92 107.77 49.14 57.30 49.81 29.30 46.30 63.55 23.70 48.57 28.11 52.29 66.47 59.99 47.52
NCI/ADR-RES 94.46 81.94 47.96 99.18 24.02 32.86 36.55 17.58 3.67 36.03 44.05 45.40 54.77 14.02 52.06
SK-OV-3 97.77 47.99 72.13 75.06 82.97 26.10 99.00 80.08 95.87 68.44 88.99 85.05 43.56 82.43 64.02
renal cancer 786-0   113.25 84.28 92.28 87.70 38.94 80.43 97.04 71.40 83.46 92.98 68.16 43.58 96.24 68.65
A498 103.70 92.16 98.87 141.89 106.80 58.98 79.95 92.59 91.34 107.83 90.96 136.18 103.28 92.30 104.93
ACHN 96.18 110.84 44.83 80.22 67.59 61.09 71.52 72.71 111.72 80.79 77.61 69.02 65.32 72.75 56.39
CAKI-1 81.89 93.22 45.87 87.58 46.28 31.84 64.04 72.08 69.51 48.65 73.63 81.82 55.08 62.58 28.75
RXF 393 104.03 90.76 56.13 79.87 72.64 14.13 74.78 90.59 83.02 55.93 88.27 52.33 38.41 49.41 61.80
SN12C 82.18 98.10 67.70 79.39 69.58 64.79 38.19 70.68 96.63 73.66 27.14 80.79 76.12 77.75 71.63
TK-10 120.42 88.46 95.63 99.80 93.11 68.70 90.74 104.96 72.43 113.60 101.93 91.77 95.83 105.47 108.92
UO-31 60.69   62.50   30.26 60.54 60.75 42.13   36.50 75.65   71.89 50.93 62.92
prostate cancer PC-3 83.21 83.14 80.17 76.26 49.41 85.05 65.91 85.51 75.72 48.11 82.47 80.20 87.92 68.16 81.39
DU-145 102.58 92.07 82.81 86.56 90.12 90.48 76.78 86.40 84.49 77.90 100.88 93.09 101.70 73.70 92.71
breast cancer MCF7 97.19 80.61 51.57 63.32 40.61 67.54 49.58 63.96 74.54 50.45 56.77 77.07 66.90 42.30 60.21
MDA-MB-231/ATCC 79.57   59.59   72.60 59.66 75.74 76.76   71.94 87.20   66.80 81.38 80.58
HS 578T   100.24 71.37 52.51 80.95 48.38 57.02 81.99 68.23 73.67 94.33 33.70 39.51 76.00 73.79
BT-549 95.55 83.27 87.40 66.42 28.16 83.67 71.72 72.57 77.08 24.05 92.35 79.69 70.98 58.51 93.63
T-47D 89.01 66.00 52.46 58.60 9.14 60.21 33.60 46.14 58.91 14.63 32.42 67.90 60.60 35.97 49.34
MDA-MB-468 99.02 66.15 41.27 43.43 28.48 50.44 54.99 41.44 56.62 31.66 64.90 64.96 57.69 30.23 46.73